KELOWNA, BC, Oct. 30, 2018 /PRNewswire/ – Liht Cannabis Corp. (CSE: LIHT) (OTCQX: LIHTF) (FSE: 2M0) (“Liht”) or the “Company”) would like to provide supplemental information on how the Company intends to deal with quality assurance and shortages of cannabis in Canada, post-prohibition. Within this news release, the Company will provide our current and prospective shareholders with the steps and measures we will be taking to ensure product quality and cultivation yield.
Liht has researched product quality and yield related issues facing cannabis cultivators to aid in the development of our own methodology of growing organic cannabis that meet patients’ medical needs.
Our facilities are monitored by a series of state-of-the-art computers controlling molecular and environment reading technologies that allow the operators to “communicate” with the plants and control the growing conditions needed for each plant. This reduces the level of human error involved in the growing process.
The Company utilizes a unique lighting technology that encourages the plants own natural chemical resistance to fighting off pests and diseases. This is achieved through the adjustment of the lighting spectrum instead of through the utilization of chemicals. Our “lighting recipe” can be altered to introduce additional specific spectrums which will inhibit the growth of mold and mildew without hindering the plant development.
Through photomorphogenics, a “stage of life” control for plants giving us the ability to differentiate plant “stem cells”‘ without the use of chemicals, we will be able to control internodal (branching) spacing and overall structure of the plant. This helps us predict and control the quality of flower, the timing of harvest, the curing process post-harvest, and genetic expressions during growth. The system suppresses negative genes and enhances the environment for positive traits.
Photomorphogenics will work together with a proprietary testing and quality assurance technology known as the S5